CryoLife (AORT): Kapitalisasi marang pendapatan

Simbol lan logo merek CryoLife (AORT)

The company's price-to-sales ratio demonstrates the resilience of Artivion, Inc. (AORT) driven by global sales of bioprostheses and vascular adhesives. The current status is 1.90. R&D expenses and the risk of product quality litigation are weighing on the dynamics. Stability is further supported by a standardized approach to biomaterial utilization and strict adherence to sterility standards.

AORT Multiplikator P/S CryoLife (04.07.2022 - 17.11.2026)

Rincian analitis perusahaan artivion.com (AORT)

- rega saham lan konsensus proyeksi valuasi:
Analisis umum perusahaan:AORT CryoLife
Barang utama Artivion, Inc.

Artivion, Inc. (AORT) operates as a developer of high-tech cardiac surgery devices, which necessitates significant investment in biomedical capital and stringent quality control. An analysis of the median P/S ratio, reflecting the relationship between market capitalization and annual revenue, allows for the determination of the asset's overvaluation relative to its fundamental earnings and helps identify optimal entry points or the need to hedge against downside risks.

Pesaing Artivion, Inc.

Kapitalisasi marang pendapatan Boston Scientific Corporation BSX|Multiplikator P/S EW (Edwards Lifesciences)|ResMed Corp (RMD) - Rega marang dodolan|Insulet Corp - Multiplikator P/S|ZBH (zimmerbiomet.com) - Rasio kapitalisasi marang pendapatan|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|GMED (NuVasive) - Multiplikator P/S|TransMedics Corp (TMDX) - Koefisien rega marang pendapatan|Multiplikator P/S ATEC|Kapitalisasi marang pendapatan Enovis Corporation ENOV|Multiplikator P/S IART (integralife.com)|Multiplikator P/S Establishment Labs Corp ESTA|BBNX - Rasio rega marang pendapatan|IRMD: Rasio rega marang pendapatan|EMBC (Embecta Corp.) - Kapitalisasi marang pendapatan|Tandem Diabetes Care - Rasio kapitalisasi pasar marang pendapatan|AXGN (Axogen Surgical) - Multiplikator P/S|Rega marang dodolan SI-BONE Inc SIBN|Rasio rega marang pendapatan Orthofix Medical (OFIX)|Multiplikator P/S Bioventus Corp (BVS)|OrthoPediatrics Corp - Kapitalisasi marang pendapatan|Multiplikator P/S Treace Medical Concepts TMCI|Blade Air Mobility - Multiplikator P/S|Koefisien rega marang pendapatan Carlsmed, Inc. CARL|RxSight (RXST) - Rasio rega marang pendapatan|Rasio rega marang dodolan CLPT (ClearPoint)|Rasio rega marang pendapatan stereotaxis.com|Kapitalisasi marang pendapatan Neuronetics, Inc. (STIM)|Multiplikator P/S SGHT|OBIO - Rega marang dodolan|Rasio rega marang pendapatan anikatherapeutics.com ANIK|NSPR: Rasio kapitalisasi marang pendapatan|ZJYL: Kapitalisasi marang pendapatan|Vivani Medical Inc - Kapitalisasi marang volume dodolan|XTNT (Xtant Medical Holdings) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan NMTC|Rasio rega marang pendapatan Modular Medical Inc|Rega marang dodolan Myomo Inc MYO|Kapitalisasi marang pendapatan COCH (Envoy Medical, Inc.)|Rasio rega marang pendapatan VVOS (vivoslife.com)|enVVeno Medical Corp. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan SINT (sintx.com)|TNON - Rasio rega marang pendapatan|LFWD: Rasio rega marang pendapatan|autonomix.com (AMIX) - Rasio rega marang pendapatan|Rega marang dodolan invobioscience.com (IVF)|BBLG (Bone Biologics Corp.) - Multiplikator P/S|Axonics Modulation Technologies (AXNX) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan BIOL (Biolase, Inc.)|Dynatronics - Rasio kapitalisasi marang pendapatan|Paragon 28, Inc. - Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan INVO Bio (INVO)